Clin2
NCT07078942Possibly a fitNot yet recruiting

Tranexamic acid to reduce bleeding during cesarean section

Pregnant Women Undergoing Cesarean Delivery

Treatments studied

Part of Blood & lymphatic, Women’s health & pregnancy clinical trials.

This study tests whether giving tranexamic acid, a medicine that helps blood clot, before a cesarean section can reduce blood loss during and after the surgery. It may help women who are at higher risk of bleeding during delivery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
98 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are pregnant and between 37 and 42 weeks of pregnancy.
  • You are scheduled for a cesarean section (C-section) for reasons such as placenta previa, severe preeclampsia, uterine fibroids, large baby, too much amniotic fluid, having had 5 or more previous deliveries, or prolonged labor.
  • You have no known allergy to tranexamic acid.
  • You have no history of blood clots (deep vein thrombosis, pulmonary embolism), heart attack, stroke, or seizures.
  • You do not have heart, kidney, or liver disease, and you have not taken blood-thinning or antiplatelet medicines within the last week.
  • You do not have placenta accreta, placental abruption, eclampsia, HELLP syndrome, or a failed vacuum or forceps delivery, and you are not carrying more than one baby.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07362992Recruiting· Early Phase 1
Tranexamic acid gel to reduce bleeding during cesarean

This study tests whether applying a medicine called tranexamic acid directly to the uterus during a scheduled cesarean can reduce bleeding. It may help women who are having their first or second cesarean delivery.

Holon, Central District
NCT06604325Recruiting
Tranexamic acid to reduce blood loss during c-section

This trial tests whether giving a medicine called tranexamic acid before a cesarean section (c-section) can help reduce the amount of blood loss during the surgery. It may be an option for women having either a planned or unplanned c-section.

Fatehpur, Uttar Pradesh
NCT04304625Recruiting· Phase 3
Tranexamic acid to reduce blood loss after C-section

This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.

Bordeaux
NCT07390799Not yet recruiting
Tranexamic acid to prevent bleeding in repeat c-section

This study tests whether giving tranexamic acid during a repeat cesarean section can reduce blood loss and prevent heavy bleeding. It may help if you are having a second or third c-section and are considered low risk for bleeding problems.

Izmir, Menemen
NCT05370820Recruiting· Phase 2
Tranexamic acid to prevent heavy bleeding after C-section

This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.

Washington D.C., District of Columbia
NCT07474077Not yet recruiting· Phase 3
Tranexamic acid to prevent heavy bleeding after C-section

This trial tests whether giving tranexamic acid during a C-section can reduce the risk of heavy bleeding after childbirth. It may help women who have certain risk factors for postpartum hemorrhage.

Hear when a new Pregnant Women Undergoing Cesarean Delivery trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.